Literature DB >> 17996595

Immune therapies.

Rao H Prabhala1, Nikhil C Munshi.   

Abstract

Immune cells with specific functions and abilities are vital to cancer treatment prevention. Although there have been many accomplishments made in the areas of immunotherapy and immunobiology of myeloma, there are still many obstacles in the way of conceptualizing the interrelationships between immune cells and tumor cells. To provide better understanding of these concepts and to move toward improved therapies for myeloma, cell-based therapeutic approaches should be developed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996595      PMCID: PMC2716007          DOI: 10.1016/j.hoc.2007.08.011

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  83 in total

1.  Dysfunctional T regulatory cells in multiple myeloma.

Authors:  Rao H Prabhala; Paola Neri; Jooeun E Bae; Pierfrancesco Tassone; Masood A Shammas; Charles K Allam; John F Daley; Dharminder Chauhan; Elizabeth Blanchard; Hemant S Thatte; Kenneth C Anderson; Nikhil C Munshi
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

2.  Dendritic cells as the terminal stage of monocyte differentiation.

Authors:  K A Palucka; N Taquet; F Sanchez-Chapuis; J C Gluckman
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

3.  Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.

Authors:  Masahiro Ono; Hiroko Yaguchi; Naganari Ohkura; Issay Kitabayashi; Yuko Nagamura; Takashi Nomura; Yoshiki Miyachi; Toshihiko Tsukada; Shimon Sakaguchi
Journal:  Nature       Date:  2007-03-21       Impact factor: 49.962

4.  Clinical trial designs for the early clinical development of therapeutic cancer vaccines.

Authors:  R M Simon; S M Steinberg; M Hamilton; A Hildesheim; S Khleif; L W Kwak; C L Mackall; J Schlom; S L Topalian; J A Berzofsky
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

5.  Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma.

Authors:  A Liso; K E Stockerl-Goldstein; S Auffermann-Gretzinger; C J Benike; V Reichardt; A van Beckhoven; R Rajapaksa; E G Engleman; K G Blume; R Levy
Journal:  Biol Blood Marrow Transplant       Date:  2000       Impact factor: 5.742

6.  Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12.

Authors:  Jianlin Gong; Shigeo Koido; Dongshu Chen; Yasuhiro Tanaka; Lei Huang; David Avigan; Kenneth Anderson; Tsuneya Ohno; Donald Kufe
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

7.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

8.  Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.

Authors:  Eva V Acosta-Rodriguez; Laura Rivino; Jens Geginat; David Jarrossay; Marco Gattorno; Antonio Lanzavecchia; Federica Sallusto; Giorgio Napolitani
Journal:  Nat Immunol       Date:  2007-05-07       Impact factor: 25.606

9.  Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.

Authors:  Daniel Mucida; Yunji Park; Gisen Kim; Olga Turovskaya; Iain Scott; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Science       Date:  2007-06-14       Impact factor: 47.728

10.  Heterogeneity of mucin gene expression in normal and neoplastic tissues.

Authors:  S B Ho; G A Niehans; C Lyftogt; P S Yan; D L Cherwitz; E T Gum; R Dahiya; Y S Kim
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

View more
  3 in total

1.  Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma.

Authors:  Yoon Joong Kang; Wanyong Zeng; Weihua Song; Bruce Reinhold; Jaewon Choi; Vladimir Brusic; Takuto Yamashita; Aditya Munshi; Cheng Li; Stephane Minvielle; Kenneth C Anderson; Nikhil Munshi; Ellis L Reinherz; Tetsuro Sasada
Journal:  Br J Haematol       Date:  2013-08-30       Impact factor: 6.998

Review 2.  New strategies in the treatment of multiple myeloma.

Authors:  Nikhil C Munshi; Kenneth C Anderson
Journal:  Clin Cancer Res       Date:  2013-03-20       Impact factor: 12.531

3.  Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma.

Authors:  R H Prabhala; M Fulciniti; D Pelluru; N Rashid; A Nigroiu; P Nanjappa; C Pai; S Lee; N S Prabhala; R L Bandi; R Smith; S B Lazo-Kallanian; S Valet; N Raje; J S Gold; P G Richardson; J F Daley; K C Anderson; S A Ettenberg; F Di Padova; N C Munshi
Journal:  Leukemia       Date:  2015-08-21       Impact factor: 11.528

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.